文献速递头颈外科

喉癌、下咽癌及p16阴性口咽癌选择性淋巴结放疗剂量与体积缩减的结局

Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16-Negative Oropharyngeal Cancers.
PubMed 文献 · Head Neck · 2025-06-14

该研究纳入73例接受同步放化疗的喉癌、下咽癌及p16阴性口咽癌或原发灶不明鳞癌连续病例,将选择性淋巴结放疗剂量降至40 Gy,中位随访23.3个月。结果显示无孤立性选择性淋巴结复发,6例局部区域复发、8例远处复发、2例同时局部区域和远处复发,所有局部区域复发均位于70 Gy靶区内。结论认为选择性淋巴结放疗剂量缩减未导致孤立性选择性淋巴结复发。

要点

  • 73例连续病例接受同步放化疗,选择性淋巴结放疗剂量降至40 Gy,中位随访23.3个月。
  • 无孤立性选择性淋巴结复发病例。
  • 6例局部区域复发、8例远处复发、2例同时局部区域和远处复发,所有局部区域复发均位于70 Gy靶区内。

核心结论

  • 对于喉癌、下咽癌及p16阴性口咽癌,选择性淋巴结放疗剂量缩减未导致孤立性选择性淋巴结复发。

研究设计与样本

  • 研究为连续队列研究,纳入73例接受同步放化疗的喉癌、下咽癌及p16阴性口咽癌或原发灶不明鳞状细胞癌患者,将选择性淋巴结放疗剂量降至40 Gy。

主要发现

  • 中位随访23.3个月,无孤立性选择性淋巴结复发病例。
  • 6例患者出现局部区域复发,8例出现远处复发,2例同时出现局部区域和远处复发。
  • 所有局部区域复发均发生在70 Gy靶区内:3例位于原发肿瘤靶区,3例位于受累淋巴结靶区,2例位于两者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reducing elective nodal irradiation dose can decrease treatment toxicity and improve quality of life for head and neck cancer patients. METHODS: We determined the effectiveness of reducing elective radiotherapy doses to 40 Gy for a consecutive cohort of laryngeal, hypopharyngeal, and p16-negative oropharyngeal or unknown primary squamous cell carcinomas treated with concurrent chemoradiation. The primary outcome measure was solitary elective nodal recurrence. RESULTS: The cohort included 73 consecutive patients with a median follow up of 23.3 months. There were no cases of solitary elective nodal recurrence. Six patients had locoregional recurrence, eight had distant recurrence, and two had simultaneous locoregional and distant recurrence. All locoregional recurrences occured in the 70 Gy target volume (three in the primary tumor target, three in the involved node target, and two in both). CONCLUSIONS: Reduction in elective nodal radiation dose did not lead to solitary elective nodal recurrences for laryngeal, hypopharyngeal, and p16-negative oropharyngeal cancers.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Zakeri K, Wren SD, Shang T, et al. Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16-Negative Oropharyngeal Cancers. Head Neck. 2025. PMID: 40515499. doi:10.1002/hed.28217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。